Reports that scientists in the U.S. have developed a protein delivery system that responds to exogenous treatment with a small molecule. Creation of chimeric proteins that contain the coding sequence for a conditional aggregation domain (CAD) fused to a proinsulin; Accumulation of CAD fusions in the endoplasmic reticulum.